Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Schulz

Showing results (871-880 of 906) with videos related to

Pageof 91
Sort By:
Cerebellum (London, England)|May 22, 2026
A Patient-Reported Outcome Measure of Communication Difficulties in Friedreich Ataxia: COMATAXMaresa Buchholz, Victoire Monier, Claire Ewenczyk, et al.
Journal of Neurochemistry|September 14, 2017
Frequent genes in rare diseases: panel-based next generation sequencing to disclose causal mutations in hereditary neuropathiesMaike F Dohrn, Nicola Glöckle, Lejla Mulahasanovic, et al.
Translational Neurodegeneration|April 16, 2019
No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptorsFranziska Hopfner, Stefanie H Müller, Dagmar Steppat, et al.
The Lancet. Neurology|March 20, 2018
Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort studyAlhassane Diallo, Heike Jacobi, Arron Cook, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 26, 2011
Depression comorbidity in spinocerebellar ataxiaTanja Schmitz-Hübsch, Mathieu Coudert, Sophie Tezenas du Montcel, et al.
Cerebellum (London, England)|June 25, 2011
Spinocerebellar ataxia types 1, 2, 3 and 6: the clinical spectrum of ataxia and morphometric brainstem and cerebellar findingsHeike Jacobi, Till-Karsten Hauser, Paola Giunti, et al.
Orphanet Journal of Rare Diseases|February 15, 2022
Dual guidance structure for evaluation of patients with unclear diagnosis in centers for rare diseases (ZSE-DUO): study protocol for a controlled multi-center cohort studyHelge Hebestreit, Cornelia Zeidler, Christopher Schippers, et al.
Movement Disorders Clinical Practice|October 27, 2018
Body Mass Index Decline Is Related to Spinocerebellar Ataxia Disease ProgressionAlhassane Diallo, Heike Jacobi, Tanja Schmitz-Hübsch, et al.
Nature Genetics|February 11, 2004
Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2Maria-Céu Moreira, Sandra Klur, Mitsunori Watanabe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 19, 2019
Prediction of Survival With Long-Term Disease Progression in Most Common Spinocerebellar AtaxiaAlhassane Diallo, Heike Jacobi, Arron Cook, et al.
Pageof 91

Showing results (871-880 of 906) with videos related to

Sort By:
Pageof 91
Cerebellum (London, England)|May 22, 2026
A Patient-Reported Outcome Measure of Communication Difficulties in Friedreich Ataxia: COMATAXMaresa Buchholz, Victoire Monier, Claire Ewenczyk, et al.
Journal of Neurochemistry|September 14, 2017
Frequent genes in rare diseases: panel-based next generation sequencing to disclose causal mutations in hereditary neuropathiesMaike F Dohrn, Nicola Glöckle, Lejla Mulahasanovic, et al.
Translational Neurodegeneration|April 16, 2019
No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptorsFranziska Hopfner, Stefanie H Müller, Dagmar Steppat, et al.
The Lancet. Neurology|March 20, 2018
Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort studyAlhassane Diallo, Heike Jacobi, Arron Cook, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 26, 2011
Depression comorbidity in spinocerebellar ataxiaTanja Schmitz-Hübsch, Mathieu Coudert, Sophie Tezenas du Montcel, et al.
Cerebellum (London, England)|June 25, 2011
Spinocerebellar ataxia types 1, 2, 3 and 6: the clinical spectrum of ataxia and morphometric brainstem and cerebellar findingsHeike Jacobi, Till-Karsten Hauser, Paola Giunti, et al.
Orphanet Journal of Rare Diseases|February 15, 2022
Dual guidance structure for evaluation of patients with unclear diagnosis in centers for rare diseases (ZSE-DUO): study protocol for a controlled multi-center cohort studyHelge Hebestreit, Cornelia Zeidler, Christopher Schippers, et al.
Movement Disorders Clinical Practice|October 27, 2018
Body Mass Index Decline Is Related to Spinocerebellar Ataxia Disease ProgressionAlhassane Diallo, Heike Jacobi, Tanja Schmitz-Hübsch, et al.
Nature Genetics|February 11, 2004
Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2Maria-Céu Moreira, Sandra Klur, Mitsunori Watanabe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 19, 2019
Prediction of Survival With Long-Term Disease Progression in Most Common Spinocerebellar AtaxiaAlhassane Diallo, Heike Jacobi, Arron Cook, et al.
Pageof 91